No Detail Found!

Cell Transplantation Therapies to Reverse Type 1 Diabetes: A review

Author(s)
Amrah Inam Department of Biological Sciences, Faculty of Basic and Applied Sciences, International Islamic university Islamabad, Pakistan.
Zia Alam Department of Biotechnology, Abdul Wali Khan University Mardan (23200), KP Pakistan.
Obaid Ullah Shah Department of Biotechnology, Abdul Wali Khan University Mardan (23200), KP Pakistan.
Misbah Department of Biotechnology, Abdul Wali Khan University Mardan (23200), KP Pakistan.
Fanxiong Shi College of Animal Science and Technology, Nanjing Agriculture University, Nanjing (210095), China.
Abstract
Stem cell technology is demonstrating promising advancements in cure of diseases due its differentiation ability. Type 1 diabetes is mainly caused by autoimmune ß cells destruction. In this review, we focus on treatment procedures of Type 1 Diabetes (T1D) with numerous stem cells (SCs) i.e hPSCs, MSCs, hESCs, BMSCs, AFSCs, HSCs and islet cells (that are not stem cells but they are approved worldwide and are being successfully used to permanently reverse T1D). A brief overview of this disease along with the advancements in treatment of T1D with stem cells is discussed. Biomaterial encapsulation to avoid immune rejection and improved immunomodulation and immune tolerance via drugs /bioengineering techniques makes the outcomes of SC therapies more efficient and productive, hence, proving to be another future milestone of completely reversing type 1 diabetes especially in those patients who got clinically diagnosed at an early stage and then received prompt treatment of eitherrestoration of already available ß cells functionality or transplantation of purified and functional SCs differentiated insulin producing cells to normalize the glycemic control and homeostasis.
Publication Details
Page(s) 95-111
Published Journal: Abasyn Journal of Life Sciences, Volume: 4, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Type 1 diabetes, stem cells, Biomaterial, ß-cells
References
Ashcroft FM,Rorsman P . .Diabetes mellitus and the β cell: the last ten years. Cell. 2012 Mar, 16(6) : 1160-71.
Sharp SA,Weedon MN,Hagopian WA,Oram RA. . .Clinical and research uses of genetic risk scores in type 1 diabetes. Current opinion in genetics & development. 2018 Jun, 1 : 96-102.
Nyaga DM,Vickers MH,Jefferies C,Perry JK,O'Sullivan JM. . .The genetic architecture of type 1 diabetes mellitus. 2018 Dec, 5 : 70-80.
McLaughlin KA,Richardson CC,Ravishankar A,Brigatti C,Liberati D,Lampasona V,Piemonti L,Morgan D,Feltbower RG,Christie MR . .Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes. 2016 Jun, 1(6) : 1690-8.
Walther D,Eugster A,Jergens S,Gavrisan A,Weinzierl C,Telieps T,Winkler C,Ziegler AG,Bonifacio E. . .Tetraspanin 7 autoantibodies in type 1 diabetes. Diabetologia. 2016 Sep, 1(9) : 19736.
Steck AK,Vehik K,Bonifacio E,Lernmark A,Ziegler AG,Hagopian WA,She J,Simell O,Akolkar B,Krischer J,Schatz D. . .Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes care. 2015 May, 1(5) : 808-13.
Lehuen A,Diana J,Zaccone P,Cooke A .2010 .Im mune cell crosstalk in type 1 diabetes. Nature Reviews Immunology, 10(7) : 501-13.
Willcox A,Richardson SJ,Bone AJ,Foulis AK,Morgan NG .2009 .Analysis of islet inflammation in human type 1 diabetes. Clinical & Experimental Immunology, 155(2) : 73-81.
Walker LS,von Herrath M. CD4 .2016 .T cell differentiation in type 1 diabetes. Clinical & Experimental Immunology, 183(1) : 16-29.
Atkinson MA,Eisenbarth GS,Michels AW . .Type 1 diabetes. The Lancet. 2014 Jan, 4(9911) : 698-2.
Katsarou A,Gudbjörnsdottir S,Rawshani A,Dabelea D,Bonifacio E,Anderson BJ,Jacobsen LM,Schatz DA,A. DA .2017 .Type 1 diabetes mellitus. Nat Rev Dis, Primers3 : 17016.
Imagawa A,Hanafusa T,Miyagawa JI,Matsuzawa Y. . .A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. 2000 Feb, 3(5) : 301-7.
Regnell SE,Lernmark Å . .Early prediction of autoimmune (type 1) diabetes. Diabetologia. 2017 Aug, 1(8) : 1370-81.
D'Addio F,Valderrama Vasquez A,Ben Nasr M .2014 .Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes, 63(9) : 3041-3046.
Trzonkowski P,Bacchetta R,Battaglia M,Berglund D,Bohnenkamp HR,Ten Brinke A,Bushell A,Cools N,Geissler EK,Gregori S . .Hurdlesin therapy with regulatoryT cells. 2015 Sep, 9(304) : 304ps18.
Thomson AW,Zahorchak AF,Ezzelarab MB,Butterfield LH,Lakkis FG,Metes DM . .Prospective clinical testing of regulatory dendritic cells in organ transplantation. 2016 Jan, 28 : 15.
Broichhausen C,Riquelme P,Geissler EK,Hutchinson JA . .Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation. 2012 Aug, 1(4) : 332-42.
Stendahl JC,Kaufman DB,Stupp SI . .Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell transplantation, 18(1) : 1-2.
Pixley JS . .Mesenchymal stem cells to treat type 1 diabetes. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease. 2020 Apr, 1(1866) : 165315.
Murai N,Ohtaki H,Watanabe J,Xu Z,Sasaki S,Yagura K,Shioda S,Nagasaka S,Honda K,Izumizaki M. . .Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin- induced type 1 diabetic mice. 2017 Oct, 12(10) : e0186637.
Rekittke NE,Ang M,Rawat D,Khatri R,Linn T. .2016 .Regenerative therapy of type 1 diabetes mellitus: from pancreatic islet transplantation to mesenchymal stem cells. 2016 Mar, 7 : .
English K. . .Mesenchymal stem cells to promote islet transplant survival. 2016 Dec, 1(6) : 568-73.
Vegas AJ,Veiseh O,Gürtler M,Millman JR,Pagliuca FW,Bader AR,Doloff JC,Li J,Chen M,Olejnik K,Tam HH . .Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. 2016 Mar;22, (3) : 306.
Sneddon JB,Tang Q,Stock P,Bluestone JA,Roy S,Desai T,Hebrok M. . .Stem cell therapies for treating diabetes: progress and remaining challenges. 2018 Jun, 1(6) : 810-23.
Spence A,Tang Q. . .Restoring regulatory T cells in type 1 diabetes. 2016 Nov, 1(11) : 110.
Trivedi HL,Vayikra AV,Thakker U,Firoze A,Dave SD,Patel CN,Patel JV,Bhargava AB,Shankar V .2008 .Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc, 40(4) : 1135-9.
Trivedi HL,Thakkar UG,Vanikar AV,Dave SD .2011 .Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells. Case Reports. 2011 Sep, 5 : bcr0720114436.
Dave SD,Trivedi HL,Chooramani SG,Chandra T. .2013 .Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells. Case Reports. 2013 Jul, 26 : bcr2013200226.
Carlsson PO,Schwarcz E,Korsgren O . .Le Bla nc K. Preserved β -cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015 Feb, 1(2) : 587-92.
Carlsson PO,Schwarcz E,Korsgren O,Le Blanc K. Preserved O . .-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015 Feb, 1(2) : 587-92.
Kondo Y,Toyoda T,Inagaki N,Osafune K. . .iPSC technology-based regenerative therapy for diabetes. 2018 Mar;9, (2) : 234-43.
Shahjalal HM,Dayem AA,Lim KM,Jeon TI,Cho SG . .Generation of pancreatic β cellsfor treatment of diabetes: advances and challenges. Stem cell research & therapy. 2018 Dec, 1(1) : 355.
Pagliuca FW,Melton DA . .How to make a functional-βcell. 2013 Jun, 140(12) : 2472-83.
Stabler CL,Li Y,Stewart JM,Keselowsky BG JM . .Engineeri ng immunomodulatory biomaterials for type 1 diabetes. 2019 Jun;4, (6) : 429-50.
Al-Khawaga S,Memon B,Butler AE,Taheri S,Abou-Samra AB,Abdelalim EM .2018 .Pathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis. Biological Reviews, 93(1) : 364-89.
Jennings RE,Berry AA,Kirkwood-Wilson R,Roberts NA,Hearn T,Salisbury RJ,Blaylock J,Hanley KP,Hanley NA . .Development of the human pancreas from foregut to endocrine commitment. Diabetes. 2013 Oct, 1(10) : 3514-22.
Stagner JI,Rilo HL,White KK . .The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. Jop. 2007 Sep, 7(5) : 628-36.
Canibano-Hernandez A,del Burgo LS,Espona-Noguera A,Ciriza J,Pedraz JL . .Current advanced therapy cell-based medicinal products for type-1-diabetes treatment. 2018 May, 30(1-2) : 107-20.
Opara E.C.,Mirmalek-Sani S.H.,Khanna O.,Moya M.L.,Brey E.M. .2010 .Design of a bioartificial pancreas(+). J. Investig. Med, 58 : 831-837.
Langlois G,Dusseault J,Bilodeau S,Tam SK,Magassouba D,Hallé JP . .Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. 2009 Nov, 1(9) : 3433-40.
Stabler C,Wilks K,Sambanis A,Constantinidis I. . .The effects of alginate composition on encapsulated βTC3 cells. Biomaterials. 2001 Jun, 1(11) : 1301-10.
Omer A,Duvivier-Kali V,Fernandes J,Tchipashvili V,Colton CK,Weir GC . .Lon-tgerm normoglycemia in rats receiving transplants with encapsulated islets. Transplantation. 2005 Jan, 15(1) : 52-8.
Hering BJ,Clarke WR,Bridges ND .2016 .Phase 3 trial of transplantation of human islets in type 1 diabetes complicated bysevere hypoglycemia. Diabetes Care, 39 : 1230-40.
Kasputis T,Clough D,Noto F,Rychel K,Dye B,Shea LD . .Microporous polymer scaffolds for the transplantation of embryonic stem cell derived pancreatic progenitors to a clinically translatable site for the treatment of type I diabetes. ACS biomaterials science & engineering. 2018 Apr, 17(5) : 17708.
Shapiro AM,Lakey JR,Ryan EA .2000 .Islet transplantation in seven patients with type 1diabetes mellitus usingaglucocorticoid-free immunosuppressive regimen. N Engl J Med, 343 : 230-38.
Rickels MR,Liu C,Shlansky-Goldberg RD,Soleimanpour SA,Vivek K,Kamoun M,Min Z,Markmann E,Palangian M,Dalton-Bakes C . .Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes. 2013 Aug, 1(8) : 2890-7.
Gerber PA,Locher R,Zuellig RA,Tschopp O,Ajdler-Schaeffler E,Kron P,Oberkofler C,Brändle M,Spinas GA,Lehmann R.,Glycemia R. . .costs of simultaneous islet-kidney or islet after kidney transplantation versus intensive insulin therapy and waiting list for islet transplantation. Transplantation. 2015 Oct, 1(10) : 2174-80.
Vantyghem MC,Kerr-Conte J,Arnalsteen L,Sergent G,Defrance F,Gmyr V,Declerck N,Raverdy V,Vandewalle B,Pigny P,Noel C . .Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes care. 2009 Aug, 1(8) : 1473-8.
Thompson DM,Meloche M,Ao Z,Paty B,Keown P,Shapiro RJ,Ho S,Worsley D,Fung M,Meneilly G,Begg I. . .Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011 Feb, 15(3) : 373-8.
Lablanche S,Vantyghem MC,Kessler L,Wojtusciszyn A,Borot S,Thivolet C,Girerd S,Bosco D,Bosson JL,Colin C,Tetaz R . .Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 2018 Jul, 1(7) : 527-37.
Speight J,Reaney MD,Woodcock AJ,Smith RM,Shaw JA .2010 .Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review. Diabetic Medicine, 27(7) : 812-22.
Ferraro A,Socci C,Stabilini A,Valle A,Monti P,Piemonti L,Nano R,Olek S,Maffi P,Scavini M,Secchi A . .Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011 Nov, 1(11) : 2903-13.
Vantyghem MC,de Koning EJ,Pattou F,Rickels MR . .Advances in β-cell replacement therapy for the treatment of type 1 diabetes. The Lancet. 2019 Oct, 5(10205) : 12748-5.
Sordi V,Pellegrini S,Krampera M,Marchetti P,Pessina A,Ciardelli G,Fadini G,Pintus C,Pantè G,Piemonti L . .Stem cells to restore insulin production and cure diabetes. 2017 Jul, 1(7) : 583-600.
Klinker MW,Wei CH . .Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. 2015 Apr, 26(3) : 556.
Sohni A,Verfaillie CM .2013 .Mesenchymal stem cells migration homing and tracking. , : .
Zhao Y,Mazzone T . .Human cord blood stem cells and the journey to a cure for type 1 diabetes. 2010 Dec, 1(2) : 103-7.
Mesples A,Zhang Y,Hu X .2013 .Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results. Medical science monitor: international medical journal of experimental and clinical research, 19 : 852.
Wu H,Wen D,Mahato RI . .Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. 2013 Sep, 1(9) : 1778-86.
Gimble JM,Katz AJ,Bunnell BA . .Adipose-derived stem cells for regenerative medicine. 2007 May, 11(9) : 1249-60.
Gerace D,Martiniello-Wilks R,Nassif NT,Lal S,Steptoe R,Simpson AM . .CRISP-tRargeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?. Stem cell research & therapy. 2017 Dec, 1(1) : 62.
Villani V,Milanesi A,Sedrakyan S,Da Sacco S,Angelow S,Conconi MT,Di Liddo R,De Filippo R . .Amniotic fluid stem cells prevent β-cell injury. Cytotherapy. 2014 Jan, 1(1) : 41-55.
D'Amour KA,Agulnick AD,Eliazer S .2005 .Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 23(12) : 1534-1541.
D'Amour KA,Bang AG,Eliazer S,Kelly OG,Agulnick AD,Smart NG,Moorman MA,Kroon E,Carpenter MK,Baetge EE . .Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature biotechnology, 24(11) : 1392-401.
Pagliuca FW,Millman JR,Gurtler M . .Generation of functional human pancreatic beta cells in vitro. Cell. 2014 Oct, 9 : 159.
Rezania A,Bruin JE,Arora P,Rubin A,Batushansky I,Asadi A,O'dwyer S,Quiskamp N,Mojibian M,Albrecht T,Yang YH . .Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature biotechnology, 32(11) : 1121.
lanus A,Holz GG,Theise ND,Hussain MA .2003 .In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest, 111(6) : 843-50.
Ersek A,Pixley JS,Goodrich AD,Porada CD,Almeida-Porada G,Thain DS . .Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells. 2010 Apr, 1(4) : 311-20.
Bonini C,Bondanza A,Perna SK,Kaneko S,Traversari C,Ciceri F,Bordignon C. . .The suicide gene therapy challenge: how to improve a successful gene therapy approach. 2007 Jul, 1(7) : 1248-52.
Yagyu S,Hoyos V,Del Bufalo F,Brenner MK . .An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells. 2015 Sep, 1(9) : 1475-85.
Guo S,Dai C,Guo M,Taylor B,Harmon JS,Sander M,Robertson RP,Powers AC,Stein R . .Inactivation of specific β cell transcription factors in type 2 diabetes. 2013 Aug, 1(8) : 3305-16.
0

Citations

0

Downloads

30

Views